Jeffrey Boone Miller Selected Research

type 2B Limb-girdle muscular dystrophy

3/2002

Up-regulation of MHC class I expression accompanies but is not required for spontaneous myopathy in dysferlin-deficient SJL/J mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey Boone Miller Research Topics

Disease

4	Facioscapulohumeral Muscular Dystrophy 05/2022 - 02/2015
3	Muscular Dystrophies (Muscular Dystrophy) 12/2013 - 01/2009
2	Muscular Diseases (Myopathy) 02/2015 - 03/2002
1	Sarcoglycanopathies 12/2016
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 02/2015
1	Paralysis (Palsy) 01/2009
1	Inflammation (Inflammations) 01/2009
1	Neuromuscular Diseases (Neuromuscular Disease) 04/2005
1	type 2B Limb-girdle muscular dystrophy 03/2002

Drug/Important Bio-Agent (IBA)

2	Transcription Factors (Transcription Factor)IBA 05/2022 - 01/2022
2	Protein Isoforms (Isoforms)IBA 04/2018 - 02/2015
2	Doxycycline (Periostat)FDA LinkGeneric 07/2011 - 01/2009
1	Sarcoglycans (beta Sarcoglycan)IBA 12/2016
1	Proteins (Proteins, Gene)FDA Link 02/2015
1	CaspasesIBA 12/2013
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2009
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2009
1	Caspase 3 (Caspase-3)IBA 01/2009
1	DystrophinIBA 04/2005
1	DysferlinIBA 03/2002